Expanded Access: Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI

Summary

This is an Intermediate-Size Expanded Access, Open-Label Study for Use of Mino-Lok Therapy (MLT) in Combination with Systemic Antibiotics in the Treatment of Central Line Associated Bloodstream Infection. Mino-Lok may be made available for patients who otherwise do not qualify for the phase 3 clinical trial (NCT02901717 )

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications